LSL Pharma Group Inc. (LSL V) stock market data APIs
C$0.3974
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
LSL Pharma Group Inc. Financial Data Overview
Price chart is built with
Anychart
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
Prev. Close
0.3974
Open
0.3974
High
0.3974
Low
0.3974
52 wk Range
0.29-0.5
Market Cap
46 213 K
P/E Ratio
13.3333
Shares Outstanding
116 M
Revenue
17 748 K
Beta
-0.28
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LSL Pharma Group Inc. data using free add-ons & libraries
Get LSL Pharma Group Inc. Fundamental Data
LSL Pharma Group Inc. Fundamental data includes:
- Net Revenue: 17 748 K
- EBITDA: 1 705 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LSL Pharma Group Inc. News
New
LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023
Revenues of $2.5M, up 25% over the last two quarters of the year;Gross margin of 18.6%, up sharply on last year's negative gross margin of (1%);Adjusted EBITDA1 of $0.1M compared with negative adjuste...
Le Groupe LSL Pharma annonce la clôture de la première tranche du placement de débentures convertibles
BOUCHERVILLE, Québec, 01 nov. 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma inc. (TSXV : LSL) – (« la Société » ou « Groupe LSL Pharma »), une société pharmaceutique intégrée canadienne, ...
LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering
BOUCHERVILLE, Québec, Nov. 01, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased...
Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million
BOUCHERVILLE, Quebec, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
